Launching global clinical trials is overwhelming every region demands unique compliance, submissions, and approval timelines. Having worked with diverse regulatory bodies (DCGI, FDA, EMA), we know how critical early readiness is. This guide gives you a clear comparison of India,…
– Public Health Emergency The Central Drugs Standard Control Organization (CDSCO) acknowledges the potential impact of COVID-19 pandemic on the healthcare system and broader society, and the impact it may have on clinical trials and subjects. The present situation across…